Mainspring Recovery, a Virginia-based addiction treatment provider, says its clinical leadership is closely monitoring the evolving overdose landscape and will continue sharing insights on the issue as new public health data emerge. As providers working directly with individuals affected by substance use disorders, Mainspring professionals say the changes reflected in state and national data mirror many of the challenges they are observing in treatment settings.
Virginia enters 2026 with signs of measurable progress in overdose mortality, alongside continued strain across emergency and behavioral health systems. The Virginia Department of Health (VDH) reports 1,403 overdose deaths among Virginia residents in 2024 (preliminary data as of January 2026), a 43% decrease compared to 2023. In 2023, the state recorded 2,463 overdose deaths, following several years of elevated mortality during the peak of the synthetic opioid surge.
State officials caution that overdose death data remain provisional until investigations and toxicology testing are finalized, a process that can take months. Recent-year counts may change as additional cases are certified. National data reflect a similar shift. The U.S. Centers for Disease Control and Prevention (CDC) reported a substantial decline in provisional overdose deaths in 2024 compared to 2023, marking the first broad national downturn after years of increases. Public health experts describe the current moment as a potential turning point, though not a resolution.
Fentanyl Continues to Drive Risk
Despite the decline in total overdose deaths, fentanyl remains the dominant substance associated with fatal outcomes in Virginia. According to VDH, approximately 79% of overdose deaths in 2023 involved fentanyl or related synthetic opioids.
The continued presence of fentanyl in the illicit drug supply contributes to elevated overdose risk because of:
- High potency relative to heroin or prescription opioids
- Frequent mixing with other substances
- Variability in drug composition and strength
VDH notes that overdose deaths are often classified across multiple drug categories, meaning a single case may involve more than one substance. This polysubstance pattern complicates prevention and treatment efforts. Even with declining mortality, fentanyl’s dominance suggests that the underlying risk environment remains unstable.
Emergency Departments and EMS Activity Remain Elevated
Fatal overdoses represent one dimension of substance use impact. In 2023, VDH recorded 21,881 drug overdose-related emergency department visits across the state. That same year, emergency medical services responded to 31,360 substance use-related incidents. Emergency department surveillance is updated more frequently than finalized death data and can serve as an early indicator of changing trends. However, like mortality data, these figures are considered preliminary and subject to revision. Providers note that many individuals who survive an overdose require immediate follow-up care, particularly structured treatment options that can support stabilization and relapse prevention.
Dr. Nicole Erkfitz, LCSW, chief operating officer at Mainspring Recovery, stated:
“An overdose is not just a medical emergency. It is a moment where the body, the brain, and a person’s life are all signaling that something must change. The period immediately following an overdose is one of the most critical opportunities for intervention. Physically, tolerance has shifted, which dramatically increases the risk of another and often fatal overdose. Emotionally and psychologically, many individuals are in a rare moment of clarity where they are more open to support and change. Structured treatment during this window can stabilize the person medically, address the underlying substance use disorder, and connect them to a recovery community before the cycle continues.”
Broader Health Consequences Persist
Substance use in Virginia continues to influence other public health indicators. VDH reports that injection drug use remains a documented risk factor in a portion of acute hepatitis C cases. Additionally, injection drug use accounted for approximately 6% of new HIV diagnoses in the state in recent reporting, underscoring the broader infectious disease implications of substance use. These secondary impacts highlight that even as overdose mortality trends improve, substance use disorders continue to intersect with chronic health conditions, behavioral health challenges, and community-level strain.
What Treatment Providers Are Observing in 2026
Across Virginia, treatment providers describe a clinical landscape characterized by increasing complexity rather than volume alone.
Common themes reported in 2026 include:
- Higher rates of co-occurring anxiety, depression, and trauma-related symptoms
- Continued relapse vulnerability associated with fentanyl exposure
- Greater demand for outpatient models that allow individuals to maintain employment or family responsibilities
Structured outpatient programs, including partial hospitalization and intensive outpatient services, have become central components of the treatment continuum in many communities. Providers indicate that continuity of care, particularly following emergency stabilization plays a significant role in sustaining recovery gains.
Yitzy Halon, co-founder of Mainspring Recovery, says:
“In 2026, one of the realities providers are facing is that the clinical needs of patients often conflict with the practical demands of life. Many individuals would benefit from starting their recovery journey in a residential level of care, but responsibilities like employment, parenting, and financial pressures make stepping away for that length of time extremely difficult. At the same time, insurance pressures often require providers and clients to step down to lower levels of care before someone is fully stabilized, which can increase vulnerability to relapse."
"Because of this, partial hospitalization and intensive outpatient programs have become essential parts of the treatment continuum. These models allow individuals to receive structured, clinically robust care while still maintaining critical life responsibilities. Providers across the field are becoming increasingly creative in how they deliver these services, offering virtual programming, evening treatment tracks, and even programs that include childcare, because the priority remains the same: removing barriers so that people can access the help they need and build a stronger foundation for recovery. Recovery does not happen in isolation from real life. Our job as providers is to build treatment models that meet people where they are so they can still receive the level of support they need.”
While provider observations offer on-the-ground perspective, public health authorities emphasize that long-term trend confirmation depends on finalized state and federal reporting.
A Cautious Turning Point
The decline in overdose deaths represents meaningful progress for Virginia after years of record-breaking mortality. At the same time, fentanyl’s continued presence, high emergency department utilization, and ongoing infectious disease risks suggest that sustained investment in prevention, harm reduction, and treatment access remains essential. As 2024 data is finalized and 2025 provisional figures mature, policymakers and providers alike will be watching whether current improvements reflect a durable shift or a temporary downturn within a complex and evolving public health challenge.
About Mainspring Recovery
Mainspring Recovery serves adults struggling with substance use disorders, including those facing co-occurring mental health challenges. It is a state-licensed and CARF accredited rehab with treatment centers in Dumfries and Triangle (NoVA) and Lynchburg (Central Virginia) offering compassionate, evidence-based care across VA. Our clients are seeking not just sobriety, but long-term healing, life skills, and a sense of purpose, and we’re here to walk that journey with them. For more information, visit www.mainspringrecovery.com.
Media Contact
Dr. Nicole Erkfitz
Mainspring Recovery
nerkfitz@mainspringrecovery.com
